Nebula Research & Development LLC Guardant Health, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 32,791 shares of GH stock, worth $1.62 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
32,791
Previous 51,845
36.75%
Holding current value
$1.62 Million
Previous $1.58 Billion
11.8%
% of portfolio
0.13%
Previous 0.19%
Shares
7 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$598 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$557 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$270 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$255 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$251 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.06B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...